Company / Revenue per Share
Neurogene Inc. Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.06
FY2025
5-year range
$0.00 / $1.07
FY2021-FY2025
Trend
-
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share returned to growth in FY2025 after 2 years of decline, reaching $0.06.
Based on SEC 10-K filings.
0.06 in FY2025.
Declined from $1.06 to $0.06 over the past 6 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.24 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | - |
| FY2024 | $0.00 | -100.0% |
| FY2019 | $1.06 | -0.3% |
| FY2018 | $1.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026